Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Nilotinib Capsules

Approval Number

国药准字HJ20171152

CompanyNovartis Pharma Schweiz AG

Registration Date

June 9, 2022

Previous Approval Numbers

H20171152

Drug Information

Generic Name

尼洛替尼胶囊

Trade Name

达希纳

Dosage Form

胶囊剂

Strength

150mg

Drug Type

化学药品

Registration Date

June 9, 2022

Expiry Date

June 8, 2027

Company Information

Applicant Company

Company NameNovartis Pharma Schweiz AG

Company Address

6343 Risch, Switzerland

Manufacturing Company

Company NameNovartis Pharma Stein AG

Company Address

Schaffhauserstrasse 4332 Stein, Switzerland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy